Aug 26, 2026 07:02AM
Aug 26, 2026 07:00AM
Aug 6, 2026 04:00PM
Jul 31, 2026 07:00AM
Jul 31, 2026 07:00AM
Jul 31, 2026 07:00AM
Jul 31, 2026 07:00AM INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Jul 30, 2026 07:00AM
Jul 30, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 15, 2026 07:01AM
Jul 15, 2026 07:00AM
Jul 15, 2026 07:00AM
Jul 9, 2026 07:00AM INmune Bio to present Phase 2 imaging data for XPro at AAIC 2026
Jul 9, 2026 07:00AM
Jul 1, 2026 07:02AM
Jul 1, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 23, 2026 08:03AM
Jun 23, 2026 08:00AM INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 13, 2026 08:00AM
May 7, 2026 04:00PM
May 5, 2026 04:00PM INmune Bio expands CORDStrom platform collaboration with Anthony Nolan
May 5, 2026 04:00PM
Apr 30, 2026 08:00AM
Apr 16, 2026 11:42AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 30, 2026 04:00PM INmune Bio reports 2025 financial results, plans regulatory filings
Mar 30, 2026 04:00PM
Mar 24, 2026 08:00AM
Mar 19, 2026 08:00AM
Feb 23, 2026 09:25AM
Feb 19, 2026 12:16PM
Feb 19, 2026 12:15PM
Feb 12, 2026 07:01AM INmune Bio receives FDA alignment on phase 2b/3 trial design for alzheimer's drug
Feb 12, 2026 07:00AM

330,180 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All